Salomon & Ludwin’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.13K | Sell |
321
-752
| -70% | -$19K | ﹤0.01% | 508 |
|
|
2025
Q1 | $27.2K | Sell |
1,073
-54
| -5% | -$1.37K | ﹤0.01% | 320 |
|
|
2024
Q4 | $29.9K | Sell |
1,127
-848
| -43% | -$22.5K | ﹤0.01% | 304 |
|
|
2024
Q3 | $57.2K | Buy |
1,975
+92
| +5% | +$2.66K | 0.01% | 244 |
|
|
2024
Q2 | $52.7K | Sell |
1,883
-7,061
| -79% | -$198K | 0.01% | 252 |
|
|
2024
Q1 | $248K | Sell |
8,944
-1,157
| -11% | -$32.1K | 0.02% | 164 |
|
|
2023
Q4 | $335K | Hold |
10,101
| – | – | 0.04% | 135 |
|
|
2023
Q3 | $335K | Sell |
10,101
-3
| -0% | -$100 | 0.04% | 135 |
|
|
2023
Q2 | $371K | Sell |
10,104
-155
| -2% | -$5.69K | 0.04% | 133 |
|
|
2023
Q1 | $419K | Sell |
10,259
-369
| -3% | -$15.1K | 0.05% | 120 |
|
|
2022
Q4 | $545K | Sell |
10,628
-300
| -3% | -$15.4K | 0.07% | 104 |
|
|
2022
Q3 | $478K | Buy |
10,928
+2,235
| +26% | +$97.8K | 0.07% | 95 |
|
|
2022
Q2 | $456K | Buy |
8,693
+1,646
| +23% | +$86.3K | 0.07% | 81 |
|
|
2022
Q1 | $365K | Buy |
7,047
+1,192
| +20% | +$61.7K | 0.05% | 81 |
|
|
2021
Q4 | $346K | Buy |
+5,855
| New | +$346K | 0.05% | 77 |
|
|
2020
Q2 | – | Sell |
-941
| Closed | -$29K | – | 174 |
|
|
2020
Q1 | $29K | Sell |
941
-1,765
| -65% | -$54.4K | 0.01% | 116 |
|
|
2019
Q4 | $101K | Buy |
2,706
+1,765
| +188% | +$65.9K | 0.02% | 76 |
|
|
2019
Q3 | $32K | Buy |
941
+738
| +364% | +$25.1K | 0.01% | 116 |
|
|
2019
Q2 | $8K | Sell |
203
-121
| -37% | -$4.77K | ﹤0.01% | 171 |
|
|
2019
Q1 | $13K | Buy |
324
+121
| +60% | +$4.86K | ﹤0.01% | 150 |
|
|
2018
Q4 | $8K | Buy |
+203
| New | +$8K | ﹤0.01% | 163 |
|